台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國邑*

(6875)
  • 股價
    56.9
  • 漲跌
    ▼0.7
  • 漲幅
    -1.22%
  • 成交量
    197
  • 產業
    上櫃 生技醫療類股▼0.42%
  • 8人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
國邑* (6875)籌碼相關-元大-古亭 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-古亭 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/21157.1000.0057.6012710.37%
2024/10/09165.5000.0064.6013280.30%
2024/10/07270.0000.0068.0023240.62%
2024/09/24561.6600.0060.9052951.69%
2024/09/23362.9000.0062.8032971.01%
2024/09/19265.8000.0066.0022940.68%
2024/09/0200.00462.9366.00-4289-1.38%
2024/08/30161.8000.0062.0012800.36%
2024/08/29160.8000.0060.8012790.36%
2024/08/2600.00361.0060.50-3277-1.08%
2024/08/23761.8400.0061.5072742.55%
2024/08/2200.00566.9066.90-5251-1.99%
2024/08/16257.1500.0057.0022510.80%
2024/08/06350.77148.4549.9522780.72%
2024/08/05354.8700.0053.6032721.10%
2024/08/01157.5000.0058.3012690.37%
2024/07/30156.8000.0058.3012670.37%
2024/07/26257.4500.0059.5022790.71%
2024/07/22360.8000.0060.8032881.04%
2024/07/19164.4000.0064.0012940.34%
2024/07/17167.1000.0067.1012890.35%
2024/07/12164.8000.0064.8013060.33%
2024/07/10265.0500.0065.2023170.63%
2024/07/09366.1300.0065.8033290.91%
2024/07/08167.1000.0067.2013330.30%
2024/07/03668.0300.0068.8063411.76%
2024/06/12269.3500.0069.5024860.41%
2024/05/2700.00975.8775.60-9763-1.18%
2024/05/23276.9000.0077.0028300.24%
2024/05/2200.00279.0077.10-2839-0.24%
2024/05/21277.3500.0077.0028440.24%
2024/05/1700.00276.0075.90-2863-0.23%
2024/04/26466.0000.0064.5049370.43%
2024/04/25665.7000.0065.3069320.64%
2024/04/24168.1000.0067.8019220.11%
2024/04/22369.6700.0068.1039190.33%
2024/04/19170.4000.0069.2019140.11%
2024/04/18369.6300.0069.0039090.33%
2024/04/16470.8000.0071.7049050.44%
2024/04/15278.45274.6073.7008950.00%
2024/04/1200.00180.6079.80-1880-0.11%
2024/04/11380.4300.0080.7038720.34%
2024/04/08483.0000.0081.2048580.47%
2024/04/01282.40384.3786.90-1835-0.12%
2024/03/29680.13180.4080.0058130.61%
2024/03/281285.02485.2583.1087871.02%
國邑*吸入新藥完成澳洲一期臨床 預計年底完成與美國FDA Pre-IND會議Anue鉅亨-2024/10/23
國邑* 相關文章
國邑* 相關影音